Andras Szasz

St. Istvan University

Professor Andras Szasz was born on 04 November 1947 in Budapest, Hungary. He studied physics at Eotvos University and became department leader in 1985. Later he changed the subject to biophysics and worked at St. Istvan University as head of Biotechnics Department.
He was visiting professor at Strathclyde University, Glasgow, UK; at Pazmany Peter Catholic University, Budapest, Hungary and at Chiba University, Chiba, Japan.
He is Chief Scientific Officer of Oncotherm Hungary and Oncotherm Germany.
The number of his publications is 400+ which includes articles and conference abstracts, he is co-author of eight books and 40+ patents. Professor Szasz is the developer of the method ‘oncothermia’.

dont miss

Modulated electrohyperthermia (mEHT) for advanced malignant tumors

mEHT is a selective heating method, targeting the malignant cells and inducing apoptosis for their elimination from the body. The method forms DAMP and induces ICD, making the forming of tumour-specific immune reactions creating abscopal effect possible all over the human body. The method is applicable for all primary or metastatic malignant tumours, also in relapsed or refractory situations. It simultaneously increases the survival time with the quality of life.

EVEN MORE SEMINARS

  • DR Zayad Ratansi: Speaking at the Oncology Convention

    DR Zayad Ratansi
    o3 Health Ltd

    Hyperbarics within Oncology

  • Joanne Edwards: Speaking at the Oncology Convention

    Joanne Edwards
    University of Glasgow

    Role of IKK alpha in Breast Cancer

  • Stuart Dollow: Speaking at the Oncology Convention

    Stuart Dollow
    Vermilion Life Sciences Ltd

    Reengineering Medicines Development

  • Dr Richter-Heine: Speaking at the Oncology Convention

    Dr Richter-Heine
    Praxisgemeinschaft im Camparihaus

    Benefits of supporting medical garments in breast surgery

  • Professor Hisham Mehanna: Speaking at the Oncology Convention

    Professor Hisham Mehanna
    InHANSE, Institute of Cancer and Genomic Sciences, University of Birmingham

    Clinical trials that change patient care and the lessons learnt